Materials Today is dedicated to the creation and sharing of materials science knowledge and experience. Supported by Elsevier, we publish high impact peer-reviewed journals – including the number one journal in the field: Biomaterials – and books, organize academic conferences, broadcast educational webinars and so much more. Our journals provide authors and readers with comprehensive coverage across materials science, spanning ground breaking discoveries to highly specialized research; offering exceptional diversity, high quality peer review, rapid publication, maximum visibility and the widest choice. Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises.
HTL is a biotechnology company, leading the way in the design, development and production of pharmaceutical grade Hyaluronic Acid (Hyaluronan) and other functional biopolymers by fermentation.
HTL serves the pharmaceutical and medical device industries worldwide. Our clients create products for dermatology, aesthetics, ophthalmology, rheumatology, urology and more. With 25 years of proven experience, HTL is recognized for producing Hyaluronic Acid that features the highest quality standards for premium medical applications and meets every market need over the long term. By merging our expertise, passion and ambition with that of our clients, we create partnerships that result in new products and solutions to enhance current medical devices and shape the future of biopolymers.
HTL develops new biopolymers using fermentation and chemical modification processes, from laboratory scale to GMP pilot plant and commercial production.
Tailor-made Hyaluronic Acid and Hyaluronan oligosaccharides
New Glycosaminoglycans: Heparosan, Chondroitin by fermentation
Glycosaminoglycans have an increasing role as promising biomaterials for innovative medical applications. Just a few examples are the development of scaffolds for regenerative medicine, the use in implantology as a shield for surgical site and a wound healing promoter and the research on targeted therapies for cancer treatment.
HTL aims to go beyond the limits of today’s uses of its biopolymers, deliver concrete progress and create real breakthroughs for medical products and for human health. To realize this vision of innovation, HTL promotes partnership, which increases creativity and technology transfers, and accelerates innovation projects.
PANBioRA is a four-year Research and Innovation Action funded by the European Union’s Horizon 2020 programme (GA No: 760921) aiming to develop a modular system using cross-disciplinary techniques that will predict the patient-specific response to a given biomaterial and methods for analysing novel biomaterials. It will allow the selection of the most suitable material, minimising health risks and side effects, and improving health outcomes.
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments — from outer space to the world’s highest peaks to the inner workings of the human body. With more than 10,500 Associates and a strong, team-oriented culture, Gore generates annual revenues of $3.7 billion.
OviGenex LLC offers an innovative portfolio of ovine collagen-based product lines that energize the scientific community and the development pipelines of our industry partners.
Our commitment to innovation led to the development of CollOvine™, a bovine and porcine alternative that is a highly purified, USDA certified, fully traceable, and TSE-free Ovine collagen with no detectable levels of Endotoxins. It offers advantageous properties for use in a variety of industries and applications such as reagents, drug delivery, tissue scaffold development, cell therapy development and medical devices.
Our passion for science led us to pioneer the development of functionalized collagen derivatives such as Maleimide, Thiolated, and Methacrylated. These derivatives allow our commercial partners to conjugate their ligand(s) of choice to promote cell adhesion, and crosslinked collagen can be used for 3D matrices.
To contact the team and learn more about how our development pipeline can energize yours, visit us at www.OviGenex.com
Dublin City University (DCU) is a young, ambitious and vibrant university, with a mission ‘to transform lives and societies through education, research, innovation and engagement’. Known as Ireland’s ‘University of Enterprise and Transformation’, DCU [https://www.dcu.ie/] is committed to the development of talent and the discovery and translation of knowledge that advances society and the economy.
DCU is ranked among the top 2% of universities globally and has featured in the world’s Top 100 Young Universities since 2012. DCU is placed 84th in the Times Higher Education University Impact Rankings – measuring higher education institutions’ contribution towards the UN Sustainable Development Goals, and is the leading Irish university in the area of technology transfer, as reflected by licensing of intellectual property. Recently DCU was awarded The Sunday Times ‘University of the Year’ 2021 in recognition of its many achievements, most notably its commitment to equity of access to education and its transformative student experience.
DCU’s international excellence in R&D has helped position Ireland as a leader in developing biomaterials and medical device technologies that have provided affordable transformative solutions for chronic diseases. DCU’s investment in attracting academics and researchers of international calibre has paid dividends in terms of developing significant facilities for biomaterials and MedTech research in Ireland, examples include the SFI Research Centre for Advanced Manufacturing, SFI Centre for Research in Medical Devices, SFI Research Centre for Advanced Materials and Bioengineering Research and the SFI Research Centre for Pharmaceuticals.
DCU also plays a leading role in trailblazing multidisciplinary initiatives including Biodesign Europe [https://biodesign.asu.edu/Research/Biodesign-Europe/overview], our flagship research partnership with Arizona State University’s Biodesign Institute, which comprises of a collection of use-inspired research centres focussed on driving technological advancement at the intersection of nature and the made-world across healthcare technology, sustainable manufacturing, biotechnology, bioanalytical systems and sustainability for health; the European Consortium of Innovative Universities [https://www.eciu.org/] and the Young European Research Universities Network [https://www.yerun.eu/], entities that advance research, education, innovation, entrepreneurship, global engagement and translation to address technological, social, economic and environmental challenges.
King’s College London was founded in 1829 and is the 4th oldest university in England. King’s has a long history of researchers who have made a significant impact to knowledge and man-kind, examples include Rosalind Franklin, who made the crucial discovery of DNA’s structure in 1953 (‘photo 51’), Thomas Hodgkin, who first described Hodgkin Lymphoma in 1832, Joseph Lister, the founder of antiseptic medicine, to name but a few. King’s has been well represented in the Nobel Laureates over the years, including Charles Barkla for his research into x-rays and other emissions in 1917, Owen Richards for pioneering ‘thermionics’ in 1928, Maurice Wilkens who was awarded the Nobel prize for the discovery of the structure of DNA in 1962.
King’s is a research-led university, and a member of the Russel Group, and is one of the top 10 universities world-wide (QS World University Rankings 2020). Based in the heart of London, it has a distinguished reputation in providing world-class education and cutting-edge research and offers outstanding opportunities for research, attracting researchers world-wide. https://www.kcl.ac.uk/aboutkings) https://www.kcl.ac.uk/aboutkings/strategy/index
King’s has a strong and distinct foundation across many disciplines; spread over 5 campuses and 9 faculties with over 31,000 students, from 150 countries. Health is a dominant and unifying theme at Kings’ College London, internationally recognized for excellence in biomedical and health research and training. It is the largest centre for the education of healthcare professionals, with Dentistry at King's College London being ranked 1st in the world. https://www.kcl.ac.uk/dentistry
King’s hosts more than 25 externally awarded centres of excellence, including four NIHR Research Centres and these are strategically aligned with King’s Health Partners bringing together academics and clinicians to facilitate applied research to be translated into clinical practice. The Wellcome EPSRC centre for medical engineering is one of the largest centres in Europe for medical imaging research. https://medicalengineering.org.uk/overview/
King’s is a partner in the London Centre for Nanotechnology, which combines state-of-the-art fundamental research in biomaterials, engineering and physics https://www.london-nano.com/
Queen Mary University of London, Mile End Road, London, E1 4NS, UK
Queen Mary University of London was founded from four institutions: St Bartholomew’s Hospital Medical College, London Hospital Medical College, Westfield College and Queen Mary College. All were founded to improve the lives of people with less privilege. St Bartholomew’s Hospital Medical College and The London Hospital Medical College were established to improve the health of the local communities in the City and east London. Westfield College and Queen Mary College provided education to women and working class communities in the East End, respectively, at a time when these groups faced extreme barriers to education.
The Department of Materials started the first Biomaterials degree in the UK in the 1980s and as part of the School of Engineering and Materials Science continues with undergraduate and MSc degrees as well as PhD training.
Biomaterials developed at Queen Mary include:
· HAPEXÔ a composite of hydroxyapatite reinforced polyethylene used in Smith & Nephew middle ear implants one, of the first bioactive composites used clinically.
· Actifuse® and Inductigraft®/Altapore®, osteostimulatory, phase-pure, porous, silicate substituted calcium phosphate bone graft substitutes, with tailored hierarchical porosities, now supplied by Baxter Healthcare.
· BioMinFÒ and BioMenCÒ bioglass containing toothpastes supplied by BioMin Technologies Ltd, a Queen Mary spin-out company https://www.biomin.co.uk
NB Blizard is named after someone a there is only one Z (honest). “Sir William Blizard, who is famous for his teaching of anatomy, physiology and surgery, as well as for his wide interests, including charitable work, social reform and writing poetry.”
Aspect Biosystems is a privately held biotechnology platform company pioneering the microfluidic 3D bioprinting of human tissues. Our proprietary technology has the potential to shape every aspect of human health by enabling the creation of human tissues for medical research, therapeutic discovery, and regenerative medicine. We are focused on partnering with academic institutions and biopharma companies to facilitate high-value discovery and development. We are also advancing internal tissue therapeutic programs for regenerative medicine, with an initial focus on metabolic diseases and musculoskeletal injuries and disorders. Learn more at:
Biomomentum manufactures & commercializes the all-in-one Mach-1™ mechanical testing device for compression, tension, shear, friction, torsion & indentation mapping of tissues & biomaterials. Unlike other micro/nanoindenters, this device is the only tester that can automatically 3D map the shape and mechanical properties of curved samples. The Mach-1™ is used in many university labs and is deemed an excellent educational tool for students. Biomomentum also provides GLP-compliant testing services.
Biomomentum Inc. 970 Michelin, suite 200 Laval, QC, H7L5C1, Canada 450-667-2299
Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
AFM (atomic force microscopy) is an advanced multiparametric imaging technique which delivers 3D profiles of the surfaces of molecules and cells in the nm-range and the characterization of their nanomechanical properties. JPK NanoWizard® BioAFMs are uniquely capable of performing high-speed studies of the time-resolved dynamics associated with cellular processes. The nanoscale structure of individual biomolecules can be resolved at high-speed scan rates of up to 1,000 lines/sec. Direct correlation of quantitative AFM and super-resolution (STED) datasets is possible, as well as a seamless combination with optical techniques, e.g. epifluorescence, confocal, and TIRF. JPK BioAFMs can be applied to study a wide-range of biological samples, from individual biomolecules to mammalian cells and tissues, in real-time, in-situ experiments.
Bruker’s Hysitron BioSoft in-situ indenter provides a unique combination of force sensitivity and large displacement range to measure the mechanical properties of biological specimens from the cellular to tissue level. This portable biomechanical test system integrates with inverted optical or fluorescent microscopes and provides an open platform for fluidic and environmental control.
The Hysitron TI 980 TriboIndenter is an advanced nanomechanical test instrument, equipped with nanoDMA III, in-situ SPM imaging, and Raman mapping capabilities. Spatially synchronized Raman spectroscopy enables direct correlation of mechanical characterization at the nanoscale to the local chemical composition.
Whatever your application, Bruker has a high-performance, industry-leading instrumentation solution to take your research to the next level.
CELLINK is a global leader in developing and delivering life-science solutions, equipping hundreds of labs and thousands of scientists worldwide with cutting-edge technologies that fuel groundbreaking scientific breakthroughs. With a commitment to quality and innovation, our bioprinters, imaging systems and bioinks have contributed to revolutionary advancements in academic and clinical medicine.
CELLINK’s solutions advance and accelerate the discovery process for customers in more than 50 countries, including university, hospital, pharmaceutical, public and commercial laboratories. Our domain knowledge, dedication to innovation and passion for excellence has positioned us as the driving market force in the fields of bioprinting and 3D cell culturing. We strive to push the limits of what is possible in regenerative medicine and pharmaceutical development, inspiring and empowering collaborators to expand their horizons and overcome any challenge they face. Join us on our journey to change the future of medicine
CellScale was founded in 2005 with the goal of making custom mechanical test systems developed at the University of Waterloo available to other researchers. Since then, we have developed a line of mechanical testing products and cell stimulation products. Our BioTester remains the market leader for biaxial testing of biomaterials, while our newly launched MicroTester pushes the boundaries of high resolution micro-scale testing. We also do custom solutions for your specific testing needs. Contact us for a demonstration, sample testing or a quote!
DURECT Corporation is a leader in the manufacture and world-wide distribution of biodegradable polymers for the pharmaceutical and medical device industries. We invite you to explore our virtual exhibit to learn more about the use of LACTEL® Absorbable Polymers for applications such as 3D bioengineered tissue scaffolds in regenerative medicine, and biodegradable films for localized drug delivery. Researchers are processing LACTEL Polymers using a variety of printing, electrospinning, solvent casting and other techniques for device fabrication.
Select from a large inventory available for prompt delivery – or take advantage of our reasonably-priced custom synthesis by which we can manipulate the properties and microstructure of the polymer in order to meet the requirements of a project. Whether your need is small batches with varying specifications for early stage work, or bulk, commercial scale supply, DURECT has the experience and capability to partner with you. Please contact us to discuss how we can help.
Our portfolio of LACTEL Polymers is produced in our dedicated, GMP facility in Birmingham, Alabama. As the first commercial source of these materials in the U.S., we have decades of experience in polymer chemistry and development. We maintain both Drug and Device Master Files with the FDA, and can provide support for product registrations in other countries as well.
The Company was established in 2010 as a spin-out by the UK Science and Technology Research Council (STFC). We are located in brand-new, purpose-built clean-room facilities on the growing Harwell Science and Innovation Campus, near Oxford, in the UK.
We offer design and development services to translate electrospun scaffold innovations to scalable, clinic-ready products. We design with a focus on downstream cost-of-goods, production scale-up and suitability for regulatory clearance. We can provide a full suite of documentation such as design history files to support regulatory submissions. We manufacture and supply FDA-approved electrospun materials since 2016.
Our team has the expert know-how to design, develop and manufacture materials for use in regenerative medical devices and for 3D cell culture. Our capabilities include ISO Class VII cleanrooms, electrospinning equipment from different manufacturers, mechanical and laser cutting, drying and annealing, sonic welding and packaging. We hold ISO 13485:2016 medical device quality certification.
Our electrospun polymer scaffolds provide an ideal environment for supporting the growth of cells in 3D. We manufacture a range of ready-to-use, sterile tissue culture plates containing the Mimetix® scaffold for tissue engineering, regenerative medicine and drug discovery research and a range of more porous materials for use in bioreactors.
Evonik is a global biomaterials leader that serves as a development partner and solutions provider to pharmaceutical and medical device companies. For more than three decades, our RESOMER® portfolio of standard and custom bioresorbable polymers have helped customers to enhance the safety, performance and supply security of their implantable medical devices and long-acting injectable drug products. Our Endexo™ portfolio of surface modification macromolecules enhance the biocompatibility of medical devices that come in contact with blood, tissue, or other biological fluids to reduce thrombosis, infection and biofouling risks. Earlier this year, Evonik also announced the development of a new recombinant collagen platform that is animal-origin free and fermentation-based with high biocompatibility, solubility and scalability. We also provide a range of application technology services for medical devices, CMO services for biomaterials, and CDMO and aseptic filling services for complex parenteral drug products. Evonik’s global network for biomaterials includes cGMP manufacturing sites in the U.S. and Germany, plus specialized biomaterial design and synthesis centers and labs in these and other regions including China.
GeSiM was founded 1995 as a spin-off from the Rossendorf Research Center. The company is a non-public and privately held entity.
Building upon a broad expertise in micromachining technologies, GeSiM has evolved into a bioinstrumentation company focusing on submicroliter liquid handling instruments, 3D bioprinting machinesand microfluidics.
With thevastly improved BioScaffold printers,GeSiMoffers an even more versatile3D printing solutionforbiological and biocompatible materials intissue engineering and medical research. The multi-Z-axes print headallows the combination ofrigidscaffoldsprovidingmechanical supportwith cell-friendly soft materialssuch as hydrogels. Up to three pneumaticallyor piston-driven extruders can print alginate, collagen, bone cement, or moltenPCL, to name a few, at temperatures from 4 to 250 °C.
To extend the functionality of the GeSiM BioScaffold printers, an optionalpiezoelectric or solenoid valve pipetting unit allows depositionof tiny drops of cells, proteins, orother biomaterialonto or inbetweenscaffolds.Amelt electro writing module enablesprintingoftiny polymer struts. The machine reads in CAD data in the STL format.
The numerous options make the GeSiM BioScaffoldprintersto the most versatile instrumentsof theirkind. In addition, the GeSiM expertise extends the robotic platform with microfluidicdevices for e.g. cell cultivation or screening if desired.
The new BS5.x printers allow 3D printing with bioinks and biocompatible polymerson a production scale. These machines come with building platforms up to half a meter, while keeping accuracy and versatility of their smaller pendants.
IOP Publishing provides a range of journals, books, websites, magazines, conference proceedings and services through which leading-edge scientific research is distributed worldwide.
Extending to more than 20 journals IOP biosciences is dedicated to providing the essential content covering all areas of medical physics, biophysics and biomedical engineering. Visit iopscience.org/biosciences.
IOP ebooksTM is an award-winning book programme that brings together innovative digital publishing with leading voices in scientific, technical, engineering and medical (STEM). Link to: iopscience.org/books
At the heart of Nissan Chemical’s operations you’ll find general chemical products and a lot more. Today we are moving ahead with a keen focus on our major growth engines. Nissan Chemical creates new products and businesses which are the pillars of our future in performance materials and life sciences other than pharmaceuticals and electronic-chemicals. prevelex® is new bio-compatible coating materials which can coat on narrow structures made with PDMS, COP and so on. FCeM® is medium which can float cells and they never precipitate. Please visit our booth.
Optics11 Life introduces innovative analysis instruments for the life sciences field. At WBC 2020, we present our new Pavone instrument, designed to enable a quantitative, semi-automated high throughput analysis of the mechanical properties of any soft and/or living material, such as cells, (engineered) tissues or particles. The Pavone integrates high-throughput mechanical analysis with automated microscopy, while providing full incubation capabilities and up to 96-well plate compatibility. An easy-to-use touchscreen-based interface allows you to set up large automated experiments, reducing time spent at the instrument and maximizing throughput.
In case, you would like to explore the possibilities of the Pavone to strengthen your R&D or QC goals, please visit us at the WBC 2020 conference or contact Pierre Duval (firstname.lastname@example.org).
Readily3D manufactures ultra-rapid and easy-to-use 3D printers for the bioprinting market based on a revolutionary new process called volumetric printing. It prints complex centimetre-scale scaffolds with soft biogels in a matter of seconds instead of hours and with the resolution needed for supporting the appropriate cell growth and development.
REGENHU is a research driven, Swiss MedTech bioprinter pioneer committed to assisting the research and scientific communities by creating and developing state-of-the art bioprinting technologies to revolutionize medicine. Founded in 2007, the dynamic and rapidly expanding company is based in VIllaz-St-Pierre, Switzerland, with offices in the United States and distributors in Asia and Oceania.
Rheolution Inc. manufactures mechanical testing devices for soft biomaterials. The ElastoSens™ Bio2 allows contactless, non-destructive testing of hydrogels and features removable sample holders for long range studies. Only equipment able to monitor 3D bioprinted scaffolds mechanical properties on the market. With real-time measurements, temperature control, volume detection, and tracking of up to three samples simultaneously, the ElastoSens™ Bio2 will simplify and streamline your research. Rheolution is based in Montreal and has opened its operations in Europe in 2018.
As the most recent strategic segment within Rousselot, we have drawn upon Rousselot’s 125+ years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop X-Pure®, an innovative range of purified gelatins and collagens specifically designed for (bio)medical applications. Offering unique advantages to assure performance, quality and safety, X-Pure is backed by strong scientific data and on-going research. Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help “Advancing medical science”. _Hlk16611892Rousselot is the global leader of collagen-based solutions1 for the food, health & nutrition, biomedical and pharmaceutical sectors and a brand of Darling Ingredients.
Sigma-Aldrich Materials Science is a leading provider of materials for use in energy, biomedical, and electronics research. Our inorganic and organic chemicals, polymers, nanomaterials, and materials for electronics and alternative energy are used in research and manufacturing worldwide. We support innovation through development and distribution of state-of-the-art materials, scientific collaboration, custom development and manufacturing. Sigma-Aldrich Materials Science is a strategic technology initiative of Merck KGaA, Darmstadt, Germany. For more information, visit sigma-aldrich.com/matsci or email email@example.com.
The Royal Society of Chemistry is an internationally renowned publisher of high quality chemical science knowledge.Our expanding portfolio of journals, books and databases feature research by an acclaimed and international set of authors.
Around the world, we invest in educating future generations of scientists. We raise and maintain standards. We partner with industry and academia, promoting collaboration and innovation. We advise governments on policy. And we are committed to promoting, supporting and celebrating diversity – championing every one of the talented groups and individuals who are securing chemistry’s future.
AIP Publishing is a wholly owned not-for-profit subsidiary of the American Institute of Physics (AIP). Our mission is to support the charitable, scientific and educational purposes of AIP through scholarly publishing activities in the fields of the physical and related sciences on our own behalf and on behalf of our publishing partners. AIP Publishing’s portfolio of journals and conference proceedings provide scientists, engineers, researchers and students a foundation of interdisciplinary and emerging basic and applied research. Our flagship journals Applied Physics Letters,Journal of Applied Physics, and The Journal of Chemical Physics give rise to new techniques and offer inspiration to contemporary researchers. Other prestigious titles published cover plasmas, fluids, mathematical physics, instrumentation, and education.
Altergon is a leading Pharmaceutical Company in the biotech production of Ultrapure Hyaluronic Acid (Sodium Hyaluronate Bulk), as well as in the production of Patches and Orodispersible Films. The Purification of Hyaluronate is the strong Altergon know-how, worldwide patented, and we are qualified suppliers of Ultrapure Hyaluronic Acid Bulk (SHYALT®) for injectable use. Altergon has a high level formulation and development know-how and an extensive regulatory experience in US and EU. Moreover, Altergon provides a wide range of services for the pharmaceutical industry: R&D services, fulfillment of the project, development of formulations and drug delivery technologies (pharma and Medical Device).
Applied Sciences (ISSN 2076-3417) provides an advanced forum on all aspects of applied natural sciences. It publishes reviews, research papers and communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. Electronic files and software regarding the full details of the calculation or experimental procedure, if unable to be published in a normal way, can be deposited as supplementary electronic material.
Indexing: SCIE (IF 2.474); Scopus (CiteScore 2.4)
21 Sections, EBM 1367
Advantages: Fast Publication; High Visibility; Free for Readers; Low Publication Fee
Fast Publication in 2019: Median Time to Publication: 37 days
CaP Biomaterials, founded by experts with over 60 years’ experience in the industry, custom-designs and manufactures calcium phosphates to customers’ specific requirements. These materials have been applied to standard biomedical applications including orthopedic, trauma, spine and dental fields. In addition, CaP Biomaterials innovates new applications for calcium phosphate, which include urinary incontinence, vocal fold augmentation, and cosmetic fillers.
CaP serves as a partner in customer growth by providing state-of-the-art testing capabilities for new and/or improved products and applications
Corbion Biomaterials develops, manufactures and markets synthetic resorbable (co)polymers based on lactide, glycolide and caprolactone monomers worldwide under the PURASORB® brand name. You can start your project assured that our polymers have already proven themselves as they are used extensively in various medical device and pharmaceutical applications such as resorbable surgical sutures, orthopaedic implant devices and controlled drug delivery systems.
With our products and service we can help you in your development from early stage R&D to commercial manufacturing. This can, for example, consist of guidance in the selection of the type of PURASORB polymer to meet your requirements, custom synthesis of a specific polymer grade and/or contract manufacturing of a resorbable polymer that your company has developed. With our know-how and experience, Corbion is excited to be your partner and we look forward to together keep creating a better quality of life for patients.
Find out how our 40+ years of experience can be of value to your project!
InnoRegen, Inc. was created upon the establishment of a regenerative medical research center, an organization jointly set up between Kyungpook National University and US-based WFIRM (Wake Forest Institute of Regenerative Medicine), a global leader of regenerative medicine.
WFIRM is internationally recognized as an authority on the area of regenerative medicine as several fundamental principles of tissue engineering and regenerative medicine were established here for the first time.
Furthermore, they are conducting initiatives with more than 400 organizations and governments, academic groups, industrial partnerships and start-up companies all around the world.
InnoRegen, Inc. has created a bioink lineup in a way that accomplishes the goal of providing treatments through cell regeneration based on our exceptional technological capabilities and was recognized for the outstanding quality at Biofabrication in 2016.
InnoRegen, Inc. is committed to develop and provide standardized bioinks that are optimally formulated for bioprinting of cells, tissues, and organs. Our mission is to contribute to the advancement of bioprinting/biofabrication field that will change the way medicine is practiced.
Materials (ISSN 1996-1944; CODEN: MATEG9) is a peer-reviewed open access journal of materials science and engineering published semi-monthly online by MDPI. It has been indexed by the Science Citation Index Expanded (Web of Science), Ei Compendex and other databases. The 2019 Impact Factor is 3.057 and the median publishing time is around 30 days.
Bioengineering (ISSN 2306-5354; CiteScore 3.14) is an international scientific peer-reviewed open access journal on the science and technology of bioengineering published quarterly online by MDPI. The journal provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Its aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. Bioengineering is covered by leading indexing services, including PubMed (Medline), Scopus (CiteScore 4.7), BIOSIS (Web of Science) and Inspec (IET).
The Society For Biomaterials is a multidisciplinary society of academic, healthcare, governmental and business professionals dedicated to promoting advancements in all aspects of biomaterial science, education and professional standards to enhance human health and quality of life.
Our experience and expertise, dedication to quality, and ingenuity has given TESco a solid long-standing reputation in the bioabsorbable medical device field. For nearly 40 years, we have manufactured challenging and complex devices using customized material selection and innovative processing techniques to deliver the clinical utility you need.
TESco offers clients advanced and personalized options that set us apart, with proprietary polymer and biocomposite material formulations to satisfy both established and cutting-edge material needs. We support our clients from concept to commercial production, providing innovative solutions to help you succeed. It is our mission to build a lasting and collaborative partnership that will serve to deliver the quality and originality you need, now and in the future.
It’s the knowledge age – and it’s Wiley’s customers who lead the world’s knowledge economy.
Our customers drive progress by providing quality education, the right skills to fulfil global demand and scientific research to fuel innovation. Our customers care, their organizations succeed and the world benefits.
Wiley develops digital education, learning, assessment and certification to help universities, businesses and individuals bridge between education and employment and achieve their ambitions.
We partner with learned societies and support researchers to communicate discoveries that make a difference. Our digital content, books and 1600 online journals build on a 200 year heritage of quality publishing.